SHARPE, GARY L., MR. – Trademark Portfolio
Entity Type: 01
SHARPE, GARY L., MR. owns a portfolio of 20 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as HCL, TILTERS, MINITWIST, UNTANGLER, and LOCK & LOCATE. Of these, 12 are registered. The portfolio spans 8 Nice Classification classes, led by Class 16 (Paper Goods) and Class 10 (Medical Apparatus). Headquartered in Dublin, OH.
Suite 150
475 Metro Place South
Dublin, OH 43017
Showing of trademarks Trademarks
Trademark Classifications
SHARPE, GARY L., MR.'s trademark portfolio spans 8 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Advertising; business management; business administration; office functions
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does SHARPE, GARY L., MR. have?
SHARPE, GARY L., MR. has 20 U.S. trademarks filed with the USPTO. Of these, 12 registered, 8 cancelled.
What trademark classes does SHARPE, GARY L., MR. file in?
SHARPE, GARY L., MR. files trademarks across 8 Nice Classification classes. The most active classes are Class 16 (Paper Goods), Class 10 (Medical Apparatus), Class 35 (Advertising & Business), Class 20 (Furniture), Class 21 (Housewares). Class 16 covers paper and cardboard; printed matter; bookbinding material; photographs; stationery.
What are SHARPE, GARY L., MR.'s most well-known trademarks?
SHARPE, GARY L., MR.'s registered trademark portfolio includes well-known marks such as HCL, TILTERS, MINITWIST, UNTANGLER, and LOCK & LOCATE. These are among 12 currently registered trademarks in the portfolio.
What is SHARPE, GARY L., MR.'s trademark registration success rate?
SHARPE, GARY L., MR. has a 60% trademark registration rate, with 12 out of 20 resolved applications resulting in successful registration. Currently, 0 applications are pending review.